Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant

BACKGROUND: There is a clear need for vaccines and therapeutics for potential biological weapons of mass destruction and emerging diseases. Anthrax, caused by the bacterium Bacillus anthracis, has been used as both a biological warfare agent and bioterrorist weapon previously. Although antibiotic th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Cassandra D, O'Loughlin, Chris, Gelder, Frank B, Peterson, Johnny W, Sower, Laurie E, Cirino, Nick M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2104530/
https://www.ncbi.nlm.nih.gov/pubmed/17953756
http://dx.doi.org/10.1186/1476-8518-5-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2104530/
https://www.ncbi.nlm.nih.gov/pubmed/17953756
http://dx.doi.org/10.1186/1476-8518-5-11

Ejemplares similares